ORIC Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	45.67	59.41	23.38	66.84	226.01
Short-Term Investments	235.82	196.55	184.8	139.43	10.97
Cash & Short-Term Investments	281.49	255.96	208.19	206.27	236.98
Cash Growth	9.97%	22.95%	0.93%	-12.96%	-19.29%
Other Current Assets	6.98	6.29	4.41	4.19	3.54
Total Current Assets	288.47	262.25	212.6	210.46	240.52
Net Property, Plant & Equipment	2.42	-	2.86	3.25	2.41
Long-Term Investments	110.76	2.92	26.85	21.95	43.39
Other Long-Term Assets	7.25	8.97	9.7	11.52	12.32
Total Assets	408.89	274.14	252.01	247.18	298.64
Accounts Payable	3.82	1.55	0.94	1.32	1.89
Accrued Expenses	16.59	23.3	19.51	14.07	13.27
Total Current Liabilities	20.42	24.85	20.46	15.39	15.15
Other Long-Term Liabilities	4.11	6.17	7.46	9.44	10.52
Total Long-Term Liabilities	4.11	6.17	7.46	9.44	10.52
Total Liabilities	24.53	31.02	27.92	24.83	25.67
Common Stock	0.01	0.01	0.01	0.01	0
Additional Paid-in Capital	1,076	805.51	658.75	557.87	518.18
Accumulated Other Comprehensive Income	0.79	0.38	0.26	-1.29	-0.1
Retained Earnings	-692.24	-562.77	-434.93	-334.23	-245.11
Shareholders' Equity	384.36	243.12	224.09	222.35	272.98
Total Liabilities & Equity	408.89	274.14	252.01	247.18	298.64
Net Cash (Debt)	281.49	255.96	208.19	206.27	236.98
Net Cash Growth	9.97%	22.95%	0.93%	-12.96%	-19.29%
Net Cash Per Share	3.21	3.67	4.05	5.20	6.24
Book Value	384.36	243.12	224.09	222.35	272.98
Book Value Per Share	4.38	3.49	4.36	5.61	7.19
Tangible Book Value	384.36	243.12	224.09	222.35	272.98
Tangible Book Value Per Share	4.38	3.49	4.36	5.61	7.19

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q